Switching to an Infliximab Biosimilar Was Safe and Effective in Dutch Sarcoidosis Patients by Bas J. M. Peters, Anish Bhatoe, Adriane D. M. Vorselaars, Marcel Veltkamp

Get full text

Quantification of pulmonary disease activity in sarcoidosis measured with 18F-FDG PET/CT: SUVmax versus total lung glycolysis by Milou C. Schimmelpennink, Adriane D. M. Vorselaars, Marcel Veltkamp, Ruth G. M. Keijsers

Get full text

Biomarkers in the Diagnosis and Prognosis of Sarcoidosis: Current Use and Future Prospects by Raisa Kraaijvanger, Montse Janssen Bonás, Adriane D. M. Vorselaars, Marcel Veltkamp, Marcel Veltkamp

Get full text

Prevalence of Novel Myositis Autoantibodies in a Large Cohort of Patients with Interstitial Lung Disease by Sofia A. Moll, Mark G. J. P. Platenburg, Anouk C. M. Platteel, Adriane D. M. Vorselaars, Montse Janssen Bonàs, Claudia Roodenburg-Benschop, Bob Meek, Coline H. M. van Moorsel, Jan C. Grutters

Get full text

Prevalence and clinical associations of myositis antibodies in a large cohort of interstitial lung diseases. by Sofia A Moll, Mark G J P Platenburg, Anouk C M Platteel, Adriane D M Vorselaars, Montse Janssen Bonàs, Raisa Kraaijvanger, Claudia Roodenburg-Benschop, Bob Meek, Coline H M van Moorsel, Jan C Grutters

Get full text

Prevalence and clinical associations of myositis antibodies in a large cohort of interstitial lung diseases by Sofia A. Moll, Mark G. J. P. Platenburg, Anouk C. M. Platteel, Adriane D. M. Vorselaars, Montse Janssen Bonàs, Raisa Kraaijvanger, Claudia Roodenburg-Benschop, Bob Meek, Coline H. M. van Moorsel, Jan C. Grutters

Get full text